Charging system in US PDUFA with reference to speeding up drug evaluation process of China

The lengthy drug evaluation period has aroused wide attention. Fee payment by pharmaceutical enterprise has become common consensus of pharmaceutical industry. This paper analysies the advantages and disadvantages of drug evaluation charging system in the US with its reference to the current situation of drug evaluation in China, with an attempt to accelerate evaluation process by properly adopting the charging system in China.